Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006)

Ítems similars

• Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
  per: Maini, R, et al.
  Publicat: (2006)
• Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
  per: Maini, R, et al.
  Publicat: (2003)
• Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
  per: Javier Narváez, et al.
  Publicat: (2015-01-01)
• UK malaria treatment guidelines (vol 54, pg 111, 2007)
  per: Lalloo, D, et al.
  Publicat: (2009)
• COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
  per: V. A. Kel'tsev, et al.
  Publicat: (2015-04-01)